Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dual beneficial effect of dopamine enhancing and neuroprotective actions of PKC delta inhibitors for treatment of Parkinson's disease

Dual beneficial effect of dopamine enhancing and neuroprotective actions of PKC delta inhibitors for treatment of Parkinson's disease

US Patent 8653023 · Granted Feb 18, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

L-DOPA microbiome therapy2023
Nano-theranostics for Parkinson's disease2023
Tyrosine kinase inhibition as a treatment for epilepsy2021
Neuroprotection by mitochondria-targeted metformin2020
Neuroprotection by mitochondria-targeted metformin2018
Neuroprotective compounds and their use2015
Design, synthesis and functional characterization of rottlerin analogs2013
Methods and compositions for inhibiting PKC delta cleavage for treatment and pre2009